Home T3 Pharmaceuticals

T3 Pharmaceuticals

acquired
Series A
Preclinical Biopharmaceuticals
Basic
Enterprise Profile

Basic Information

T3 Pharmaceuticals is a preclinical biopharmaceutical company dedicated to advancing a new generation of therapies for cancer patients. Our expert team is developing highly specific and efficient treatments using live bacteria.
T3 Pharmaceuticals AG
Basel,CantonofBasel-City,Switzerland
less than 15 people
January 01, 2015
info@t3pharma.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs